Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis
Stephen V. Faraone, Jeffrey H. Newcorn, Andrea Cipriani, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 212-219
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 82
Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response
Gonzalo Salazar de Pablo, Carolina Pastor Jordá, Julio Vaquerizo‐Serrano, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2022) Vol. 62, Iss. 2, pp. 151-168
Open Access | Times Cited: 49
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
Azmi Nasser, Joseph T. Hull, Soumya A. Chaturvedi, et al.
CNS Drugs (2022) Vol. 36, Iss. 8, pp. 897-915
Open Access | Times Cited: 39
Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review
Nathan T. M. Huneke, Jay Amin, David S. Baldwin, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 10
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review
Javier Quintero, José Ramón Gutiérrez-Casares, Cecilio Álamo
Neurology and Therapy (2022) Vol. 11, Iss. 4, pp. 1489-1517
Open Access | Times Cited: 28
Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder
Russell H. Tobe, Yajing Zhu, Teresa Gleissl, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 8, pp. 1201-1216
Open Access | Times Cited: 11
Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis
Simeng Wang, Zhiyi Xiong, Yuehua Cui, et al.
Movement Disorders (2024) Vol. 39, Iss. 3, pp. 585-595
Open Access | Times Cited: 4
Treatments in the pipeline for attention-deficit/hyperactivity disorder (ADHD) in adults
Guilherme Fusetto Veronesi, Alessandra Gabellone, Anneka Tomlinson, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 163, pp. 105774-105774
Open Access | Times Cited: 4
Role of Vitamins and Nutrients in the Management of Attention-Deficit Hyperactivity Disorder (ADHD): A Narrative Review
Rehab El-Sayed, Eman Alamri, Mohamed H. El‐Sayed, et al.
Deleted Journal (2025) Vol. 4, Iss. 1
Closed Access
Editorial: Placebo Response in Child and Adolescent Psychiatry: To Mitigate or to Harness?
Manpreet K. Singh
Journal of the American Academy of Child & Adolescent Psychiatry (2025)
Closed Access
Single–dose methylphenidate induces shift in functional connectivity associated with positive longer term clinical response in adult attention–deficit/hyperactivity disorder
Charlotte M. Pretzsch, Valeria Parlatini, Declan Murphy
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Autonomic correlates of osteopathic manipulative treatment on facial functional mapping: an innovative approach based on thermal imaging
Francesco Cerritelli, Perpetuini David, Karen Jordan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Methylphenidate dose–response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial
Karen Vertessen, Marjolein Luman, James M. Swanson, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 495-504
Open Access | Times Cited: 8
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications
Samuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105149-105149
Open Access | Times Cited: 8
Short-term effects of an elimination diet and healthy diet in children with attention-deficit/hyperactivity disorder: a randomized-controlled trial
Annick Bosch, Margreet Bierens, Verena Ly, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 5, pp. 1503-1516
Open Access | Times Cited: 8
Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis of Randomized Clinical Trials
Alok Singh, Mahesh Kumar Balasundaram, Abhishek Singh
Journal of Central Nervous System Disease (2022) Vol. 14
Open Access | Times Cited: 13
An Open-Label Study of a Wearable Device Targeting ADHD, Executive Function, and Academic Performance
Lindsay E. Ayearst, Richard Brancaccio, Margaret D. Weiss
Brain Sciences (2023) Vol. 13, Iss. 12, pp. 1728-1728
Open Access | Times Cited: 6
Utilization of Drugs for Attention-Deficit Hyperactivity Disorder Among Young Patients in China, 2010–2019
Zhiliang Wang, Xiaoyan Wu, Zhenwei Yu, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 10
Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study
Philip Asherson, Lena Johansson, Rachel Holland, et al.
The British Journal of Psychiatry (2022) Vol. 222, Iss. 1, pp. 7-17
Open Access | Times Cited: 10
Memory retention following acoustic stimulation in slow-wave sleep: a meta-analytic review of replicability and measurement quality
Tylor J. Harlow, Matthew B. Jané, Heather L. Read, et al.
Frontiers in Sleep (2023) Vol. 2
Open Access | Times Cited: 6
The Nocebo Response in Pharmacologic Treatments of Primary Headache: A Systematic Review and Meta‐Analysis
Yu Zhang, Yingying Xu, Shuping Liu, et al.
The Journal of Clinical Pharmacology (2022) Vol. 62, Iss. 10, pp. 1257-1272
Closed Access | Times Cited: 9
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice
Karen Vertessen, Marjolein Luman, Pierre M. Bet, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 319-330
Closed Access | Times Cited: 1
Placebo-related improvement with methylphenidate treatment in children with ADHD
Karen Vertessen, Jaap Oosterlaan, Pierre M. Bet, et al.
European Child & Adolescent Psychiatry (2024)
Open Access | Times Cited: 1
Systematic Review and Meta-Analysis: Placebo Response in Randomized Controlled Trials of Tourette Disorder Medications
Pedro Macul Ferreira de Barros, Luís C. Farhat, Emily Behling, et al.
Journal of the American Academy of Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 1
Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder
Adi Aran, Moria Harel, Aminadav Ovadia, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3098-3098
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top